Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9NG6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,001
Award facts
- Contract value 100% obligated
- $14,001.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,001.42 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on January 28, 2026, with completion expected by January 29, 2026. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Ondansetron is an antiemetic commonly used in military and federal healthcare settings for nausea and vomiting management. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements through the DLA Medical Supply Chain, supplying an extensive portfolio of pharmaceuticals and medical supplies across multiple therapeutic domains. The company's capability to compete successfully on a full and open basis, as demonstrated through numerous non-set-aside contract awards, reflects its established position as a critical vendor for federal military healthcare systems and other government agencies.
Quick answers
Who was awarded contract SPE2DR26F9NG6?
SPE2DR26F9NG6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F9NG6 worth?
The government has obligated $14,001 on SPE2DR26F9NG6.
Is contract SPE2DR26F9NG6 an order under another contract?
Yes. SPE2DR26F9NG6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NG6 competed?
The extent of competition for SPE2DR26F9NG6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award